Johnson Johnson
-
{
- All
- News
- Videos
-
Johnson & Johnson To Pay $966 Million In Baby Powder Cancer Case
Johnson & Johnson was told by a California jury to pay $966 million to the family of a dead woman who blamed her cancer on life-long use of the company's baby powder in the largest verdict for a single user in the 15-year litigation.
-
J&J's $8.2 Billion Settlement Linked To Iconic Baby Powder Faces Court Test
The fate of Johnson & Johnson's latest push to use bankruptcy courts to end thousands of cancer lawsuits tied to its iconic baby powder now hinges on a high-stakes trial in January.
-
Johnson & Johnson Proposes $9 Billion To Settle Cancer Claims: 5 Facts
Pharmaceutical giant Johnson & Johnson will pay $8.9 billion to settle thousands of lawsuits alleging that the talcum in its iconic baby powder caused cancer. However, the US company's proposal will need the approval of a bankruptcy court.
-
Court Rescinds Ban, Allows Johnson & Johnson To Make, Sell Baby Powder
The Bombay High Court on Wednesday permitted Johnson & Johnson to manufacture, sell and distribute its baby powder and quashed three orders of the Maharashtra government revoking the company's license.
-
Johnson & Johnson Drops Talcum Powder Globally As Lawsuits Mount
Johnson & Johnson said it plans to stop selling its legacy talc-based baby-powder products globally in 2023, a move that comes amid continued legal battles and years after the company discontinued the product in the US and Canada.
-
Johnson & Johnson Covid Booster Highly Effective Against Severe Omicron: Study
A preliminary South African government study published Thursday showed a booster of the Johnson & Johnson Covid vaccine was 85 percent effective in preventing hospitalization from the Omicron variant, a finding that helps revive the shot's reputatio
-
Moderna Or Pfizer Booster Works Well For Those Vaccinated With J&J: Study
People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
-
Johnson & Johnson Covid Vaccine Pause Continues After Experts Defer Vote
A pause on all US vaccinations with the Johnson & Johnson Covid shot will continue for at least another week after members of a government-convened expert panel said Wednesday they needed more time to assess its possible links to a clotting disorder.
-
No Causal Link Found Between J&J Vaccine, Blood Clots: US Drug Regulator
Top US health authorities said Friday they have not yet found a "causal" link between Johnson & Johnson's Covid shot and blood clots, as the EU drug regulator probed possible instances among those who have received the vaccine.
-
Johnson & Johnson Told To Pay $2.1 Billion Over Cancer-Causing Powder
A US court has upheld a verdict that talcum powder sold by Johnson & Johnson caused ovarian cancer and ordered the pharmaceutical giant to pay $2.1 billion in damages.
-
US Court Slashes $8 Billion Verdict In Johnson & Johnson Drug Lawsuit
A Pennsylvania court on Friday slashed an $8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury because the company failed to warn that a psychiatric drug could cause breast growth in men.
-
Johnson & Johnson Says New Tests Show No Asbestos In Baby Powder
Johnson & Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos after USFood and Drug Administration investigations reported trace amounts of the material in the product earlier this year.
-
J&J Directed To Pay Rs 25 Lakh To Patients For Alleged Faulty Hip Implant
The Delhi High Court on Thursday directed Johnson and Johnson to make interim payment of Rs 25 lakh each to 67 patients who have undergone revision surgeries for alleged faulty hip implants made by the company.
-
Johnson And Johnson Ordered To Pay $29 Million In Talc Cancer Trial
A California jury on Wednesday ordered Johnson & Johnson to pay $29 million to a woman who said that asbestos in the company's talcum-powder-based products, including Johnson's Baby Powder, caused her mesothelioma.
-
India's Reaction To Report On Johnson And Johnson Baby Powder
India's drug regulator said on Tuesday a news agency Reuters report that Johnson & Johnson knew for decades that cancer-causing asbestos lurked in its baby powder was "under consideration".
-
Johnson & Johnson To Pay $966 Million In Baby Powder Cancer Case
Johnson & Johnson was told by a California jury to pay $966 million to the family of a dead woman who blamed her cancer on life-long use of the company's baby powder in the largest verdict for a single user in the 15-year litigation.
-
J&J's $8.2 Billion Settlement Linked To Iconic Baby Powder Faces Court Test
The fate of Johnson & Johnson's latest push to use bankruptcy courts to end thousands of cancer lawsuits tied to its iconic baby powder now hinges on a high-stakes trial in January.
-
Johnson & Johnson Proposes $9 Billion To Settle Cancer Claims: 5 Facts
Pharmaceutical giant Johnson & Johnson will pay $8.9 billion to settle thousands of lawsuits alleging that the talcum in its iconic baby powder caused cancer. However, the US company's proposal will need the approval of a bankruptcy court.
-
Court Rescinds Ban, Allows Johnson & Johnson To Make, Sell Baby Powder
The Bombay High Court on Wednesday permitted Johnson & Johnson to manufacture, sell and distribute its baby powder and quashed three orders of the Maharashtra government revoking the company's license.
-
Johnson & Johnson Drops Talcum Powder Globally As Lawsuits Mount
Johnson & Johnson said it plans to stop selling its legacy talc-based baby-powder products globally in 2023, a move that comes amid continued legal battles and years after the company discontinued the product in the US and Canada.
-
Johnson & Johnson Covid Booster Highly Effective Against Severe Omicron: Study
A preliminary South African government study published Thursday showed a booster of the Johnson & Johnson Covid vaccine was 85 percent effective in preventing hospitalization from the Omicron variant, a finding that helps revive the shot's reputatio
-
Moderna Or Pfizer Booster Works Well For Those Vaccinated With J&J: Study
People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
-
Johnson & Johnson Covid Vaccine Pause Continues After Experts Defer Vote
A pause on all US vaccinations with the Johnson & Johnson Covid shot will continue for at least another week after members of a government-convened expert panel said Wednesday they needed more time to assess its possible links to a clotting disorder.
-
No Causal Link Found Between J&J Vaccine, Blood Clots: US Drug Regulator
Top US health authorities said Friday they have not yet found a "causal" link between Johnson & Johnson's Covid shot and blood clots, as the EU drug regulator probed possible instances among those who have received the vaccine.
-
Johnson & Johnson Told To Pay $2.1 Billion Over Cancer-Causing Powder
A US court has upheld a verdict that talcum powder sold by Johnson & Johnson caused ovarian cancer and ordered the pharmaceutical giant to pay $2.1 billion in damages.
-
US Court Slashes $8 Billion Verdict In Johnson & Johnson Drug Lawsuit
A Pennsylvania court on Friday slashed an $8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury because the company failed to warn that a psychiatric drug could cause breast growth in men.
-
Johnson & Johnson Says New Tests Show No Asbestos In Baby Powder
Johnson & Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos after USFood and Drug Administration investigations reported trace amounts of the material in the product earlier this year.
-
J&J Directed To Pay Rs 25 Lakh To Patients For Alleged Faulty Hip Implant
The Delhi High Court on Thursday directed Johnson and Johnson to make interim payment of Rs 25 lakh each to 67 patients who have undergone revision surgeries for alleged faulty hip implants made by the company.
-
Johnson And Johnson Ordered To Pay $29 Million In Talc Cancer Trial
A California jury on Wednesday ordered Johnson & Johnson to pay $29 million to a woman who said that asbestos in the company's talcum-powder-based products, including Johnson's Baby Powder, caused her mesothelioma.
-
India's Reaction To Report On Johnson And Johnson Baby Powder
India's drug regulator said on Tuesday a news agency Reuters report that Johnson & Johnson knew for decades that cancer-causing asbestos lurked in its baby powder was "under consideration".
